A BILL 
To amend the Public Health Service Act to authorize the 
Director of the National Institutes of Health to make 
awards to outstanding scientists, including physician-sci-
entists, to support researchers focusing on pediatric re-
search, including basic, clinical, translational, or pediatric 
pharmacological research, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Pediatricians Accel-
4
erate Childhood Therapies Act of 2021’’ or the ‘‘PACT 
5
Act of 2021’’. 
6
20:21 Jun 27, 2021
H3773
2 
•HR 3773 IH
SEC. 2. TRANS-NIH AWARDS FOR EARLY-CAREER PEDI-
1
ATRIC RESEARCHERS. 
2
Part G of title IV of the Public Health Service Act 
3
(42 U.S.C. 288 et seq.) is amended by adding at the end 
4
the following new section: 
5
‘‘SEC. 489A. TRANS-NIH AWARDS FOR EARLY-CAREER PEDI-
6
ATRIC RESEARCHERS. 
7
‘‘(a) IN GENERAL.—The Director of the NIH shall 
8
make awards to outstanding scientists, including physi-
9
cian-scientists, to support early-career researchers focus-
10
ing on pediatric research, including basic, clinical, 
11
translational, or pediatric pharmacological research. 
12
‘‘(b) PRIORITY RESEARCH POPULATIONS.—In car-
13
rying out subsection (a), the Director of NIH may 
14
prioritize the issuance of awards to applicants who— 
15
‘‘(1) are individual researchers presenting quali-
16
fying applications and representing populations that 
17
have been historically underrepresented in pediatric 
18
medical research, including women and underrep-
19
resented racial minorities; or 
20
‘‘(2) are institutions of higher education that 
21
are eligible to receive funds under part A or B of 
22
title III of the Higher Education Act of 1965, part 
23
A or B of title V of such Act, or subpart 4 of part 
24
A of title VII of such Act, or research institutions 
25
partnering with such institutions of higher education 
26
20:21 Jun 27, 2021
H3773
3 
•HR 3773 IH
to offer programs to support early-career pediatric 
1
researchers. 
2
‘‘(c) PRIORITY RESEARCH TOPIC AREAS.—In car-
3
rying out subsection (a), the Director of NIH, in consulta-
4
tion with the Director of the Eunice Kennedy Shriver Na-
5
tional Institute of Child Health and Human Development 
6
and the directors of other national research institutes and 
7
national centers that participate within the Trans-NIH 
8
Pediatric Research Consortium, shall— 
9
‘‘(1) establish priority research topic areas, in-
10
formed by external stakeholders, including research 
11
institutions, research societies, patient organizations, 
12
and industry; and 
13
‘‘(2) consider opportunities to align such pri-
14
ority pediatric research topic areas with current and 
15
future priorities of the National Institutes of Health, 
16
including— 
17
‘‘(A) pediatric and adolescent mental and 
18
behavioral health, including addiction medicine; 
19
‘‘(B) childhood cancer; 
20
‘‘(C) precision medicine, genetics, and 
21
genomics; 
22
‘‘(D) rare diseases and disorders, such as 
23
sickle cell disease, and other diseases and dis-
24
20:21 Jun 27, 2021
H3773
4 
•HR 3773 IH
orders with significant unmet training needs; 
1
and 
2
‘‘(E) fetal, placental, and neonatal develop-
3
ment. 
4
‘‘(d) REQUIREMENTS.—The Director of NIH— 
5
‘‘(1) shall require recipients of awards under 
6
this section to use such awards to support pediatric 
7
research activities, including costs associated with 
8
laboratory staff and other costs associated with the 
9
conduct of research; and 
10
‘‘(2) may allow recipients of awards under this 
11
section to use such awards for costs associated with 
12
receiving guidance and training from senior re-
13
searchers and mentors, as necessary to help such re-
14
cipients reach a state of research independence, in-
15
cluding conferences and other meeting participation. 
16
‘‘(e) SUPPLEMENT, NOT SUPPLANT.—Awards made 
17
under this section shall be used to supplement, and not 
18
supplant, other funding for pediatric research and pedi-
19
atric training.’’. 
20
SEC. 3. TRANS-NIH PEDIATRIC CONSORTIUM. 
21
Title IV of the Public Health Service is amended by 
22
inserting after section 409D (42 U.S.C. 284h) the fol-
23
lowing new section: 
24
20:21 Jun 27, 2021
H3773
5 
•HR 3773 IH
‘‘SEC. 409D–1. TRANS-NIH PEDIATRIC CONSORTIUM. 
1
‘‘(a) ESTABLISHMENT.—The Director of NIH shall 
2
establish and maintain a consortium to be known as the 
3
Trans-NIH Pediatric Research Consortium (in this sec-
4
tions referred to as the ‘Consortium’) to coordinate pedi-
5
atric research programs across the National Institutes of 
6
Health. 
7
‘‘(b) MEMBERSHIP.—The members of the Consor-
8
tium shall consist of representatives of multiple national 
9
research institutes and national centers. 
10
‘‘(c) CHAIR.—The Chair of the Consortium shall be 
11
the Director of the Eunice Kennedy Shriver National In-
12
stitute of Child Health and Human Development (or the 
13
Director’s designee). 
14
‘‘(d) DUTIES.—In coordinating pediatric research 
15
programs across the National Institutes of Health, the 
16
Consortium shall— 
17
‘‘(1) establish pediatric research priorities; 
18
‘‘(2) identify gaps and opportunities for re-
19
search collaborations involving multiple national re-
20
search institutes and national centers; and 
21
‘‘(3) identify opportunities to develop the next 
22
generation of pediatric researchers. 
23
‘‘(e) CONSULTATION.—The Consortium shall consult 
24
regularly with external experts in the field of pediatric re-
25
20:21 Jun 27, 2021
H3773
6 
•HR 3773 IH
search, including children’s hospitals, children’s research 
1
institutions, patient organizations, and other stakeholders. 
2
‘‘(f) REPORTING.—Beginning one year after the date 
3
of enactment of the Pediatricians Accelerate Childhood 
4
Therapies Act of 2021 and every 2 years thereafter, the 
5
Consortium shall submit to Congress, and make publicly 
6
available on the website of the National Institutes of 
7
Health, a report on— 
8
‘‘(1) any research project involving pediatrics 
9
and involving more than one Institute or Center that 
10
was supported during the review period; 
11
‘‘(2) any strategic initiatives that include a sig-
12
nificant pediatric component; 
13
‘‘(3) career development awards for early-career 
14
researchers focused in pediatrics, including specific 
15
numbers of awards and amount of funding, made 
16
during the review period; 
17
‘‘(4) details on the composition of awards for 
18
early-career researchers, including demographic de-
19
tails indicating the proportion of recipients from 
20
populations that have been underrepresented in pedi-
21
atric medical research; and 
22
‘‘(5) such other information as the Director of 
23
NIH determines appropriate.’’. 
24
Æ 
20:21 Jun 27, 2021
H3773
